Merit of the Paper "PP2A Inhibition Sensitize Cancer Stem Cells to ABL Tyrosine Kinase Inhibition in BCR-ABL Human Leukemia" Authored by Lai Et Al. [Science Translational Medicine (2019) Vol. 11, Issue 501, Eaau0416, DOI: ]

doi 10.14293/s2199-1006.1.sor-.ppyefvr.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ScienceOpen

Related search

Inhibition of Phosphotyrosine Phosphatase 1B Causes Resistance in BCR-ABL-Positive Leukemia Cells to the ABL Kinase Inhibitor STI571

Clinical Cancer Research
Cancer ResearchOncology
2006English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model

Haematologica
Hematology
2019English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Multidomain Targeting of BCR-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2013English

Effect of a Selective Abl Tyrosine Kinase Inhibitor, STI571, on in Vitro Growth of BCR-ABL-positive Acute Lymphoblastic Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

WNT/Ca2+/Nfat Signaling Maintains Survival of Ph+ Leukemia Cells Upon Inhibition of BCR-Abl

Cancer Cell
Cancer ResearchOncologyCell Biology
2010English

Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy